S100A9 and myelodysplastic syndrome: The first genetic evidence for the pathogenetic significance of MDSCs in MDS came from a study where S100A9 transgenic (Tg) mice were used as a model of the progressive expansion of MDSCs in the PB, spleen, and the BM [78], utilizing the knowledge that MDSCs can be induced by S100 proteins [73].